Evidence map›Paper›PMID 42412289›Full record

ArticleMetabolic brain disease2026

Genetic and structural characterisation of alzheimer's disease associated variants in an Eastern Indian cohort.

Dipanwita Sadhukhan, Adreesh Mukherjee, Izaz Monir Kamal, Shreyosi Maitra, Brahmachari Somnath Vedeshachaitanya, Bidisha Bhattacharyya, Atanu Biswas, Saikat Chakrabarti, Arindam Biswas

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dipanwita SadhukhanMolecular Biology & Clinical Neuroscience Division, National Neurosciences Centre, Calcutta, Kolkata, India.
Adreesh MukherjeeInstitute of Postgraduate of Medical Education & Research and Bangur Institute of Neurosciences, Kolkata, India.
Izaz Monir KamalStructural Biology and Bioinformatics Division, CSIR-Indian Institute of Chemical Biology, IICB-TRUE Campus, CN-06, CN Block, Sector V, Bidhannagar, Kolkata, West Bengal, 700091, India.
Shreyosi MaitraDepartment of Biomedical Science & Technology, School of Biological Sciences, Ramakrishna Mission Vivekananda Educational & Research Institute, Narendrapur, West Bengal, India.
Brahmachari Somnath VedeshachaitanyaDepartment of Biomedical Science & Technology, School of Biological Sciences, Ramakrishna Mission Vivekananda Educational & Research Institute, Narendrapur, West Bengal, India.
Bidisha BhattacharyyaInstitute of Postgraduate of Medical Education & Research and Bangur Institute of Neurosciences, Kolkata, India.
Atanu BiswasInstitute of Postgraduate of Medical Education & Research and Bangur Institute of Neurosciences, Kolkata, India. atabis@gmail.com.
Saikat ChakrabartiStructural Biology and Bioinformatics Division, CSIR-Indian Institute of Chemical Biology, IICB-TRUE Campus, CN-06, CN Block, Sector V, Bidhannagar, Kolkata, West Bengal, 700091, India. saikat@iicb.res.in.
Arindam BiswasMolecular Biology & Clinical Neuroscience Division, National Neurosciences Centre, Calcutta, Kolkata, India. thisisarindam@gmail.com.

Funding

Department of Biotechnology, Ministry of Science and Technology, India BT/NIDAN/01/05/2018Department of Science & Technology, Govt. of India DST/CSRI-P/2017/22
6 · The paper itself

Abstract

Alzheimer's disease (AD) shows substantial clinical heterogeneity often caused by genetic variants contributing to both familial and early-onset forms. However, the genetic landscape of AD in the diverse Indian population remains further characterised. To identify probable pathogenic variants associated with AD, representing individuals from Eastern India and to assess their potential structural effects using molecular dynamics (MD) simulations. Whole-exome sequencing was performed in 29 radiologically confirmed AD patients. Variants identified were screened using standard in silico prediction tools and categorised according to their involvement in amyloid precursor protein (APP)-related and non-APP pathways. Molecular dynamics simulations of filtered variants in PSEN1, SORL1, and ABCA7 genes were conducted using GROMACS 2024 to assess conformational stability, flexibility (RMSD, RMSF), compactness (Rg), and solvent accessibility (SASA). Thirty-six variants across 18 genes were identified, including five pathogenic variants and 31 variants of uncertain significance. Frequently affected genes included ABCA7 (8 variants), SORL1 (3 variants), PSEN1 (two novel variants), and APP (London mutation, Val717Ile). Most patients (83.3%) had a positive family history, with a mean age at onset of 54.17 ± 11.74 years, presenting with typical AD, posterior cortical atrophy, or frontal variants. MD simulations revealed increased rigidity, altered electrostatic interactions, and disrupted ATP-binding dynamics in mutant proteins compared with wild type. This study identifies novel and known AD-associated variants in an Indian cohort and demonstrates their potential structural impact. Integrating genetic and structural analyses provides valuable insights into AD pathogenesis in underrepresented populations.

Indexed as

Alzheimer DiseaseGenetic VariationAgedAmyloid beta-Protein PrecursorATP-Binding Cassette TransportersCohort StudiesExome SequencingFemaleHumansIndiaLDL-Receptor Related ProteinsMaleMembrane Transport ProteinsMiddle AgedMolecular Dynamics SimulationMutationABCA7 protein, humanAmyloid beta-Protein PrecursorATP-Binding Cassette TransportersLDL-Receptor Related ProteinsMembrane Transport ProteinsPresenilin-1PSEN1 protein, humanSORL1 protein, humanAlzheimer’s diseaseIndiansMolecular dynamicsVariantsWhole exome sequencing

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.